Phathom Pharmaceuticals Inc (PHAT) — Tangible Net Worth Ratio
Phathom Pharmaceuticals Inc (PHAT) has a Tangible Net Worth Ratio of 100.0% as of June 2023. This metric is calculated by deducting intangible assets ($0.00) from net assets ($17.60 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See PHAT net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Phathom Pharmaceuticals Inc Tangible Net Worth Ratio (2019–2021)
This chart shows how Phathom Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 3 annual periods from 2019 to 2021. As of June 2023, the ratio stands at 100.0%, reflecting net assets of $17.60 Million with intangible assets of $0.00 USD. See Phathom Pharmaceuticals Inc (PHAT) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Phathom Pharmaceuticals Inc (2019–2021)
The table below presents the year-by-year Tangible Net Worth Ratio for Phathom Pharmaceuticals Inc from 2019 to 2021, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see how much is Phathom Pharmaceuticals Inc worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 100.0% | $72.16 Million | $0.00 | $189.43 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $194.27 Million | $0.00 | $295.11 Million | ▲ +0.0 pp |
| 2019 | 100.0% | $227.96 Million | $0.00 | $257.18 Million | — |